LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina. The findings in animals may help advance treatment options for dry age-related macular ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina.

Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and ...

NIH Scientists Test in an Animal Model a Surgical Technique to Improve Cell Therapy for Dry Age-Related Macular Degeneration ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...